Mechanism of macrophage migration inhibitory factor-induced decrease of T-type Ca2+ channel current in atrium-derived cells

Experimental Physiology

Volumn 98, Issue 1, 2013, Pages 172-182

  Rao, Fang ^a   Deng, Chun Yu ^a   Wu, Shu Lin ^a   Xiao, Ding Zhang ^a   Huang, Wei ^a   Deng, Hai ^a   Kuang, Su Juan ^a   Lin, Qiu Xiong ^a   Shan, Zhi Xin ^a   Liu, Xiao Ying ^a   Zhu, Jie Ning ^a   Yu, Xi Yong ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; CALCIUM CHANNEL T TYPE; GENISTEIN; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA;

ADULT; ARTICLE; CALCIUM CURRENT; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; VOLTAGE CLAMP; WHOLE CELL;

EID: 84872170837     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2012.066761     Document Type: Article

References (39)

1. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, Tracy RP, Van Wagoner DR, Psaty BM, Lauer MS & Chung MK (2003). Inflammation as a risk factor for atrial fibrillation. Circulation 108, 3006-3010.
2. Chugh SS, Blackshear JL, Shen WK, Hammill SC & Gersh BJ (2001). Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 37, 371-378.
3. Conway DS, Buggins P, Hughes E & Lip GY (2004). Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. Am Heart J 148, 462-466.
4. 2+ channel and their roles in activity regulation. Cardiovasc Res 69, 391-401.
5. Engelmann MD & Svendsen JH (2005). Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 26, 2083-2092.
6. Erpel T & Courtneidge SA (1995). Src family protein tyrosine kinases and cellular signal transduction pathways. Curr Opin Cell Biol 7, 176-182.
7. 2+ channels and pharmacological blockade: potential pathophysiological relevance. Cardiovasc Drugs Ther 11, 723-739.
8. Fareh S, Benardeau A & Nattel S (2001). Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs. Cardiovasc Res 49, 762-770.
9. Gaborit N, Steenman M, Lamirault G, Le Meur N, Le Bouter S, Lande G, Leger J, Charpentier F, Christ T, Dobrev D, Escande D, Nattel S & Demolombe S (2005). Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation. Circulation 112, 471-481.
10. Ca, L in patients with chronic atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol 375, 383-392.
11. Hatzinikolaou-Kotsakou E, Tziakas D, Hotidis A, Stakos D, Floros D, Papanas N, Chalikias G, Maltezos E & Hatseras DI (2006). Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation. Am J Cardiol 97, 659-661.
12. 2+ channels in rabbit colonic smooth muscle cells by c-Src and focal adhesion kinase. J Biol Chem 273, 5337-5342.
13. 2+ channel gene and current in post-infarction remodeled rat left ventricle. Cardiovasc Res 46, 442-449.
14. Izumi T, Kihara Y, Sarai N, Yoneda T, Iwanaga Y, Inagaki K, Onozawa Y, Takenaka H, Kita T & Noma A (2003). Reinduction of T-type calcium channels by endothelin-1 in failing hearts in vivo and in adult rat ventricular myocytes in vitro. Circulation 108, 2530-2535.
15. 2+ current in neonatal and adult rat ventricular myocytes by the tyrosine kinase inhibitor, genistein. Eur J Pharmacol 345, 309-314.
16. Kong YZ, Yu X, Tang JJ, Ouyang X, Huang XR, Fingerle-Rowson G, Bacher M, Scher LA, Bucala R & Lan HY (2005). Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human atherosclerotic plaques. Atherosclerosis 178, 207-215.
17. Korantzopoulos P, Kolettis T, Siogas K & Goudevenos J (2003). Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress. Med Sci Monit 9, RA225-RA229.
18. Korantzopoulos P, Kolettis TM, Galaris D & Goudevenos JA (2007). The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 115, 135-143.
19. Lee SH, Yu WC, Cheng JJ, Hung CR, Ding YA, Chang MS & Chen SA (2000). Effect of verapamil on long-term tachycardia-induced atrial electrical remodeling. Circulation 101, 200-206.
20. Leistad E, Aksnes G, Verburg E & Christensen G (1996). Atrial contractile dysfunction after short-term atrial fibrillation is reduced by verapamil but increased by BAY K8644. Circulation 93, 1747-1754.
21. Livak KJ & Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the method. Methods 25, 402-408.
22. 2+ channels in ventricular cells from hypertrophied rat hearts. J Mol Cell Cardiol 31, 1617-1625.
23. Matsui Y, Okamoto H, Jia N, Akino M, Uede T, Kitabatake A & Nishihira J (2004). Blockade of macrophage migration inhibitory factor ameliorates experimental autoimmune myocarditis. J Mol Cell Cardiol 37, 557-566.
24. Ohashi N, Mitamura H, Tanimoto K, Fukuda Y, Kinebuchi O, Kurita Y, Shiroshita-Takeshita A, Miyoshi S, Hara M, Takatsuki S & Ogawa S (2004). A comparison between calcium channel blocking drugs with different potencies for T- and L-type channels in preventing atrial electrical remodeling. J Cardiovasc Pharmacol 44, 386-392.
25. Pena JM, MacFadyen J, Glynn RJ & Ridker PM (2012). High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial. Eur Heart J 33, 531-537.
26. Qu YC, Du YM, Wu SL, Chen QX, Wu HL & Zhou SF (2009). Activated nuclear factor-κB and increased tumor necrosis factor-α in atrial tissue of atrial fibrillation. Scand Cardiovasc J 43, 292-297.
27. 2+ channel depression induced by macrophage migration inhibitory factor in atrial myocytes. J Mol Cell Cardiol 47, 586-594.
28. 2+ channel activity in human atrial myocytes. J Mol Cell Cardiol 37, 735-745.
29. Sun H, Chartier D, Leblanc N & Nattel S (2001). Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes. Cardiovasc Res 49, 751-761.
30. 2+ channels. Cell Calcium 40, 97-114.
31. Tieleman RG, De Langen C, Van Gelder IC, de Kam PJ, Grandjean J, Bel KJ, Wijffels MC, Allessie MA & Crijns HJ (1997). Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation 95, 1945-1953.
32. Tsang TS, Miyasaka Y, Barnes ME & Gersh BJ (2005). Epidemiological profile of atrial fibrillation: a contemporary perspective. Prog Cardiovasc Dis 48, 1-8.
33. Van Wagoner DR (2003a). Electrophysiological remodeling in human atrial fibrillation. Pacing Clin Electrophysiol 26, 1572-1575.
34. Van Wagoner DR (2003b). Molecular basis of atrial fibrillation: a dream or a reality? J Cardiovasc Electrophysiol 14, 667-669.
35. Willis MS, Carlson DL, Dimaio JM, White MD, White DJ, Adams GA 4th, Horton JW & Giroir BP (2005). Macrophage migration inhibitory factor mediates late cardiac dysfunction after burn injury. Am J Physiol Heart Circ Physiol 288, H795-H804.
36. Yang Z, Shen W, Rottman JN, Wikswo JP & Murray KT (2005). Rapid stimulation causes electrical remodeling in cultured atrial myocytes. J Mol Cell Cardiol 38, 299-308.
37. Yokoshiki H, Sumii K & Sperelakis N (1996). Inhibition of L-type calcium current in rat ventricular cells by the tyrosine kinase inhibitor, genistein and its inactive analog, daidzein. J Mol Cell Cardiol 28, 807-814.
38. Yue L, Feng J, Gaspo R, Li GR, Wang Z & Nattel S (1997). Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res 81, 512-525.
39. Zhang Y, Talwar A, Tsang D, Bruchfeld A, Sadoughi A, Hu M, Omonuwa K, Cheng KF, Al-Abed Y & Miller EJ (2012). Macrophage migration inhibitory factor mediates hypoxia-induced pulmonary hypertension. Mol Med 18, 215-223.